Figure 1From: Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity Constructs used for CD44s re-expression in Lentivector. CD44s was expressed as a fusion protein with luciferase, or as a separate protein. CD44s in human prostate includes exons 1-5 and 16-18, with a small portion of 20, according to our sequencing[3].Back to article page